Search Results - "BAKER, Katherine L"
-
1
Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
Published in Journal of clinical oncology (20-01-2010)“…Inactivation of the von Hippel-Lindau gene in clear-cell renal cell carcinomas (RCC) leads to overexpression of hypoxia inducible factor, a transcription…”
Get full text
Journal Article -
2
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
Published in The Lancet (British edition) (30-03-2002)“…Hypersensitivity to abacavir affects about 4% of patients who receive the drug for HIV-1 infection. We did a retrospective, case-control study to identify…”
Get full text
Journal Article -
3
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
Published in The lancet oncology (01-08-2012)“…Summary Background Several targeted drugs are approved for treatment of patients with metastatic renal-cell cancer, but no validated biomarkers are available…”
Get full text
Journal Article -
4
Effect of Antacids and Ranitidine on the Single-Dose Pharmacokinetics of Fosamprenavir
Published in Antimicrobial Agents and Chemotherapy (01-01-2005)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
5
Ritonavir Increases Plasma Amprenavir (APV) Exposure to a Similar Extent when Coadministered with either Fosamprenavir or APV
Published in Antimicrobial Agents and Chemotherapy (01-04-2006)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
6
-
7
The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma
Published in Clinical cancer research (15-09-2013)“…Inactivation of von Hippel-Lindau (VHL) gene in clear-cell renal cell carcinoma (RCC) leads to increased levels of hypoxia-inducible factors (HIF) and…”
Get full text
Journal Article -
8
Abstract A11: Lower baseline levels of plasma hepatocyte growth factor, IL-6, and IL-8 are correlated with greater tumor shrinkage in renal cell carcinoma patients treated with pazopanib
Published in Molecular cancer therapeutics (10-12-2009)“…Abstract Introduction: A Phase II RCC study (VEG102616) demonstrated activity with a response rate = 34.7% (CI 95%, 28.4 – 40.9) and disease control rate (CR +…”
Get full text
Journal Article -
9
Abstract B155: A phase I study of the MEK inhibitor GSK1120212 (GSK212) in combination with PI3K/mTOR inhibitor GSK2126458 (GSK458) in patients with advanced solid tumors
Published in Molecular cancer therapeutics (12-11-2011)“…Abstract Background: This is a Phase I, open-label, dose escalation, pharmacokinetic (PK), pharmacodynamic (PD) and safety study in patients (pts) with…”
Get full text
Journal Article -
10
Patterns of L2 vocabulary development among ESL adults
Get full text
Dissertation -
11
Patterns of L2 vocabulary development among ESL adults
Published 01-01-1998“…Scope and method of study. The purpose of this study was to examine the nature and patterns of L2 vocabulary development of six ESL adults for reading a second…”
Get full text
Dissertation